Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Silexion Therapeutics Corp - Ordinary Shares (NQ: SLXN )

0.3050 -0.0020 (-0.65%)
Streaming Delayed Price Updated: 1:53 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 867,238
Open 0.2848
Bid (Size) 0.3002 (9)
Ask (Size) 0.3075 (9)
Prev. Close 0.3070
Today's Range 0.2760 - 0.3172
52wk Range 0.2070 - 4.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agilent, Bath & Body Works And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Performance

YTD
-84.36%
-84.36%
1 Month
-0.55%
-0.55%
3 Month
-81.52%
-81.52%
6 Month
-84.36%
-84.36%
1 Year
-84.36%
-84.36%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
What's Going On With Silexion Therapeutics Shares Wednesday?
Via Benzinga
US Stocks Mostly Lower; Target Posts Downbeat Earnings
Via Benzinga
Ilan Hadar, CEO of Silexion Therapeutics Corp. (NASDAQ: SLXN), to Present at NobleCon20
Via Investor Brand Network
Silexion Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Via News Direct
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit
Via News Direct
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Silexion Investigational Pancreatic Cancer Treatment Shows Promise In Animal Studies
Via Benzinga
Market Alert: Silexion Therapeutics (NASDAQ: SLXN) Sees Record Volumes Following Breakthrough Preclinical Data for SIL-204
Via News Direct
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Silexion Therapeutics Unveils Promising Preclinical Data for SIL-204 Just Days After New LODER Data: Advancing the Fight Against Pancreatic Cancer
Via AB Newswire
Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies
From Silexion Therapeutics Corp.
Via Business Wire
Silexion Therapeutics Stock Trades Higher, Trial Data For Pancreatic Cancer Patients Shows Promise
Via Benzinga
Silexion Therapeutics Reports Promising Phase 2 Data for Non-Resectable Pancreatic Cancer Treatment
Via AB Newswire
Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer
From Silexion Therapeutics
Via Business Wire
Industry Update: 3 Exciting Precision Oncology Players to Watch Following Summit’s Meteoric Rise: Silexion, Nuvectis, Scorpian
Via AB Newswire
Industry Update: 3 Exciting Precision Oncology Players to Watch Following Summit’s Meteoric Rise: Silexion, Nuvectis, Scorpian
Via News Direct
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.